Celgene Corp. to pay $280M to settle cancer drug fraud suit
Tuesday, July 25, 2017 - 18:02
in Mathematics & Economics
LOS ANGELES (AP) -- A New Jersey pharmaceutical company has agreed to pay $280 million to settle a federal lawsuit alleging it committed fraud by promoting a drug for leprosy and another therapy for unapproved cancer treatments, federal prosecutors announced Tuesday....